DSM Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,760,978
Closed -$122M 47
2025
Q2
$122M Sell
1,760,978
-295,609
-14% -$20.1M 1.8% 18
2025
Q1
$143M Buy
2,056,587
+49,175
+2% +$4.06M 2.5% 12
2024
Q4
$173M Buy
2,007,412
+286,912
+17% +$31M 2.67% 11
2024
Q3
$205M Buy
1,720,500
+126,579
+8% +$16.9M 3.13% 10
2024
Q2
$228M Buy
1,593,921
+1,593,303
+257,816% +$211M 3.3% 9
2024
Q1
$79.4K Buy
618
+166
+37% +$19.8K ﹤0.01% 58
2023
Q4
$46.8K Buy
+452
New +$44.7K ﹤0.01% 66
2016
Q1
Sell
-2,980
Closed -$87K 41
2015
Q4
$87K Hold
2,980
﹤0.01% 39
2015
Q3
$81K Hold
2,980
﹤0.01% 39
2015
Q2
$82K Sell
2,980
-970
-25% -$27.3K ﹤0.01% 40
2015
Q1
$105K Hold
3,950
﹤0.01% 38
2014
Q4
$84K Hold
3,950
﹤0.01% 43
2014
Q3
$94K Hold
3,950
﹤0.01% 75
2014
Q2
$91K Buy
+3,950
New +$87.2K ﹤0.01% 76

Other funds holding NVO